e_LS biomarkers_NNS for_IN drug_NN response_NN ._.
We_PRP utilize_VBP the_DT algorithm_NN from_IN Liu_NNP G._NNP M_NNP ,_, Wong_NNP L.M._NNP and_CC Li_NNP J.Y._NNP 's_POS paper_NN on_IN ``_`` Mining_NNP Statistically_RB Important_JJ Equivalence_NN Classes_NNS and_CC Delta-Discriminative_JJ Emerging_JJ Patterns_NN ''_'' =_SYM -_: =[_NN 9_CD -RRB-_-RRB- -_: =_SYM -_: ._.
The_DT concept_NN of_IN equivalence_JJ classes_NNS ,_, or_CC a_DT set_NN of_IN frequent_JJ itemsets_NNS that_WDT always_RB occur_VBP together_RB in_IN some_DT set_NN of_IN transactions_NNS ,_, is_VBZ utilized_VBN in_IN the_DT algorithm_NN ._.
An_DT equivalence_JJ class_NN ,_, in_IN SNP_NN biomarker_NN discov_NN
